OncoSignal

Childhood acute lymphoblastic leukemia

Relapsed and refractory disease after frontline cure rates: blinatumomab, inotuzumab and CD19 CAR-T cells.

AACR Annual Meeting 2026
17–22 Apr 2026, San Diego · Cancer Research 86 (7_Supplement)

All 7,489 abstracts, including clinical trial (CT) and late-breaking (LB) abstracts, have Cancer Research supplement DOIs in Crossref.

Indexed in Crossref

20 abstracts matching childhood acute lymphoblastic leukemia from the meeting's journal supplement, fetched live from Crossref 2026-11-12 10:58 UTC. This is a keyword search, not the complete abstract book.